✦ LIBER ✦

Chronic Use of PPI and H2Antagonists Decreases the Risk of Pouchitis After IPAA for Ulcerative Colitis

✍ Scribed by Lisa S. Poritz, Rishabh Sehgal, Arthur S. Berg…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

669 Chronic use of PPI and H2 Antagonist

✍ Poritz, Lisa S.; Sehgal, Rishabh; Berg, Arthur; Laufenberg, Lacee; Choi, Christi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB

P094 CLINICAL, SURGICAL AND GENETIC RISK

✍ M. Ferrante; S. Declerck; T. Koopman; M. Pierik; P. Rutgeerts; G. Van Assche; A. 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 88 KB

Risk of cancer in patients with chronic

✍ P. Vento; A. Lepistö; P. Kärkkäinen; A. Ristimäki; C. Haglund; H. J. Järvinen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB

The Interleukin 1 Receptor Antagonist Ge

✍ Martyn J. Carter; Francesco S. di Giovine; Angela Cox; Peter Goodfellow; Simon J 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

991 Mucosa-Associated Microbiota and Ris

✍ Scarpa, Marco; Grillo, Alessia R.; Pozza, Anna; Faggian, Diego; Ruffolo, Cesare; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Risk factors and cumulative risk for the

✍ Hata, Keisuke; Watanabe, Toshiaki; Nagawa, Hirokazu 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 149 KB